These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11914893)

  • 1. Scintigraphic follow-up of the effects of therapy with hydroxyurea on splenic function in patients with sickle cell disease.
    Santos A; Pinheiro V; Anjos C; Brandalise S; Fahel F; Lima M; Etchebehere E; Ramos C; Camargo EE
    Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):536-41. PubMed ID: 11914893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of splenic function preservation in children with sickle cell anemia treated with hydroxyurea.
    Nottage KA; Ware RE; Winter B; Smeltzer M; Wang WC; Hankins JS; Dertinger SD; Shulkin B; Aygun B
    Eur J Haematol; 2014 Nov; 93(5):377-83. PubMed ID: 24796940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tc-99m diphosphonate and sulfur colloid uptake by the spleen in sickle disease: interrelationship and clinical correlates: concise communication.
    Silberstein EB; DeLong S; Cline J
    J Nucl Med; 1984 Dec; 25(12):1300-3. PubMed ID: 6502253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preservation of spleen and brain function in children with sickle cell anemia treated with hydroxyurea.
    Hankins JS; Helton KJ; McCarville MB; Li CS; Wang WC; Ware RE
    Pediatr Blood Cancer; 2008 Feb; 50(2):293-7. PubMed ID: 17554794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved Splenic Function After Hematopoietic Stem Cell Transplant for Sickle Cell Disease.
    Nickel RS; Seashore E; Lane PA; Alazraki AL; Horan JT; Bhatia M; Haight AE
    Pediatr Blood Cancer; 2016 May; 63(5):908-13. PubMed ID: 26757445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental pattern of splenic dysfunction in sickle cell disorders.
    Pearson HA; Gallagher D; Chilcote R; Sullivan E; Wilimas J; Espeland M; Ritchey AK
    Pediatrics; 1985 Sep; 76(3):392-7. PubMed ID: 2412200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splenic phagocytic function in children with sickle cell anemia receiving long-term hypertransfusion therapy.
    Buchanan GR; McKie V; Jackson EA; Vedro DA; Hamner S; Holtkamp CA
    J Pediatr; 1989 Oct; 115(4):568-72. PubMed ID: 2795347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sickle cell diseases: What can nuclear medicine offer?
    Niccoli Asabella A; Altini C; Nappi AG; Lavelli V; Ferrari C; Marzullo A; Loiodice A; Rubini G
    Hell J Nucl Med; 2019; 22(1):2-3. PubMed ID: 30843001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia.
    Wang WC; Wynn LW; Rogers ZR; Scott JP; Lane PA; Ware RE
    J Pediatr; 2001 Dec; 139(6):790-6. PubMed ID: 11743503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment.
    Steinberg MH; Barton F; Castro O; Pegelow CH; Ballas SK; Kutlar A; Orringer E; Bellevue R; Olivieri N; Eckman J; Varma M; Ramirez G; Adler B; Smith W; Carlos T; Ataga K; DeCastro L; Bigelow C; Saunthararajah Y; Telfer M; Vichinsky E; Claster S; Shurin S; Bridges K; Waclawiw M; Bonds D; Terrin M
    JAMA; 2003 Apr; 289(13):1645-51. PubMed ID: 12672732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyurea prescription, availability and use for children with sickle cell disease in Italy: Results of a National Multicenter survey.
    Colombatti R; Palazzi G; Masera N; Notarangelo LD; Bonetti E; Samperi P; Barone A; Perrotta S; Facchini E; Miano M; Del Vecchio GC; Guerzoni ME; Corti P; Menzato F; Cesaro S; Casale M; Rigano P; Forni GL; Russo G; Sainati L;
    Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28868627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical response and adverse events in young patients with sickle cell disease treated with hydroxyurea.
    Kattamis A; Lagona E; Orfanou I; Psichou F; Ladis V; Kanavakis E; Metaxotou-Mavrommati A; Kattamis C
    Pediatr Hematol Oncol; 2004 Jun; 21(4):335-42. PubMed ID: 15205096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splenic function in Omani children with sickle cell disease: correlation with severity index, hemoglobin phenotype, iron status, and alpha-thalassemia trait.
    Wali YA; Al-Lamki Z; Hussein SS; Bererhi H; Kumar D; Wasifuddin S; Zachariah M; Ghosh K
    Pediatr Hematol Oncol; 2002; 19(7):491-500. PubMed ID: 12217195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splenic concentration of bone imaging agents in functional asplenia.
    Dhekne RD
    Clin Nucl Med; 1981 Jul; 6(7):313-7. PubMed ID: 6786810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrum of fetal hemoglobin responses in sickle cell patients treated with hydroxyurea: the National Institutes of Health experience.
    Rodgers GP
    Semin Oncol; 1992 Jun; 19(3 Suppl 9):67-73. PubMed ID: 1379375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
    Italia K; Jain D; Gattani S; Jijina F; Nadkarni A; Sawant P; Nair S; Mohanty D; Ghosh K; Colah R
    Blood Cells Mol Dis; 2009; 42(1):25-31. PubMed ID: 18954999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Splenic function in children with sickle cell disease: two different patterns in Saudi Arabia.
    Babiker MA; el-Hazmi MA; Al-Jobori AM; Obeid H; Bahakim HM
    Scand J Haematol; 1985 Aug; 35(2):191-3. PubMed ID: 4048865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splenic uptake of both technetium-99m diphosphonate and technetium-99m sulfur colloid in sickle cell beta (0) thalassemia.
    Heck LL; Brittin GM
    Clin Nucl Med; 1989 Aug; 14(8):557-63. PubMed ID: 2805534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of hydroxyurea in children with sickle cell disease: what comes next?
    Ohene-Frempong K; Smith-Whitley K
    Semin Hematol; 1997 Jul; 34(3 Suppl 3):30-41. PubMed ID: 9317199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of S-glutathionyl hemoglobin in homozygous sickle cell disease.
    Thom GG; Kallanagowdar C; Somjee SS; Velez MC; Yu LC; Hempe JM
    J Pediatr Hematol Oncol; 2009 Dec; 31(12):895-900. PubMed ID: 19855306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.